This page shows the latest European Society of Cardiology news and features for those working in and with pharma, biotech and healthcare.
Detailed results revealed at the European Society of Cardiology virtual congress. ... AstraZeneca (AZ) has revealed some impressive results from a phase 3 study of its heart failure drug Farxiga in chronic kidney disease (CKD) at the European Society of
broad diabetes patient population, most of whom had no cardiovascular disease at enrolment, compared with placebo. ... AstraZeneca’s HFrEF trial of Farxiga – named DAPA-HF – was hailed as a ‘landmark trial’ when it was presented at last
attack or stroke,” said Ruud Dobber, executive vice president of biopharmaceuticals at AZ. ... The HFrEF trial, called DAPA-HF, was presented at this year’s European Society of Cardiology (ESC) congress in Paris to some fanfare, showing that
burden. ORION-10 involved patients with atherosclerotic cardiovascular disease (ASCVD), and the results back up the earlier ORION-11 data in the same patient population which was presented at the European ... Society of Cardiology (ESC) congress
Earlier this month, AZ revealed the results of the DAPA-HF trial of its diabetes therapy Farxiga, to an eager crowd at the European Society of Cardiology. ... This hard-to-treat form of the disease currently has no approved drug therapies.
Lead investigator John McMurray of the University of Glasgow presented the results at the European Society of Cardiology (ESC) congress in Paris over the weekend to an enthusiastic audience. ... non-diabetic population and make it an option for the
More from news
Approximately 2 fully matching, plus 45 partially matching documents found.
One of my colleagues, Emma, has also incorporated virtual technology into a medical education programme. ... What value did the virtual mannequin add? . It was the first time ever a virtual mannequin had been used at the European Society of Cardiology
But when asked about their propensity to take part in programmes in relation to: (1) the sponsoring organisation (independent bodies such as the European Society of Cardiology or an unrestricted grant ... Figure 4: EU5 average of preferences of online
Professor John Camm, Chair of the European Society of Cardiology Committee for Guidelines on the Management of Atrial Fibrillation told me recently: “Well-meaning rewording of key messages to 'suit' different ... It resulted in improved cholesterol
Timescale:March 2009 to August 2009. The annual European Society of Cardiology Congress is the largest global cardiology meeting, attracting thousands of delegates and hundreds of journalists; the competition between pharmaceutical ... Merck, with a
Timescale:July 2009 to December 2009. Guest delegates of DAIICHI SANKYO UK at the European Society of Cardiology Congress were subpoenaed to appear on a jury at The Formulary Court of ... meetings and will also roll out via a series of regional GP
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Communication strategies and marketing messages were to be crafted using the outcomes data which our client planned to launch at the European Society of Cardiology (ESC) annual congress. ... meant to our clients key customers and the overall impact of
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...